Literature DB >> 18658031

Long term postischemic stroke mortality in diabetes: a veteran cohort analysis.

Masoor Kamalesh1, Jianzhao Shen, George J Eckert.   

Abstract

BACKGROUND AND
PURPOSE: Recent data on stroke mortality in diabetics in the United States is lacking. We investigated trends in diabetes prevalence and stroke morality among diabetics in a large veteran cohort.
METHODS: The Patient Treatment File was used to identify all patients discharged from any Veterans hospital between October 1990 and September 1997 with a diagnosis of ischemic stroke (ICD-9-CM codes 434, 436) listed as primary diagnosis. Demographic, morbidity, and mortality data were recorded. Chi-square tests were used to examine differences between diabetics and nondiabetics, and t tests were used for continuous variables. Cox proportional hazards regression was used to examine the effects of diabetes (DM) on the survival times controlling for multiple covariates.
RESULTS: Of 48 733 ischemic stroke patients identified, 98% were male and 13 925 (25%) had DM. Mean age was similar between DM and non-DM (67.2 versus 67.5, P=NS). Prevalence of DM among stroke subjects increased from 25% to 31%. Charlson index >2 was much higher in DM (68.2% versus 47.9%, P<0.001). Mortality at 60 days and 1 year was similar in both groups (2.9 versus 2.7%, P=NS; 12.6 versus 13.1, P=NS). Kaplan-Meier survival plot showed that DM had shorter long term survival time (log-rank, P<0.001). Multivariate Cox proportional hazards regression showed a higher risk of death for diabetics (HR=1.15, 95% CI 1.11 to 1.19, P<0.001).
CONCLUSIONS: Despite greater comorbidity, postacute ischemic stroke mortality at 60 days and 1 year is not different between subjects with and without DM. Long term mortality after stroke is much lower among DM than that reported in older studies.

Entities:  

Mesh:

Year:  2008        PMID: 18658031     DOI: 10.1161/STROKEAHA.108.517441

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Long-Term Outcomes of Stroke in a Ghanaian Outpatient Clinic.

Authors:  Fred S Sarfo; John Akassi; Gloria Kyem; Sheila Adamu; Dominic Awuah; Osei-Sarfo Kantanka; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-12-20       Impact factor: 2.136

2.  Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke.

Authors:  Justin B Echouffo-Tcheugui; Haolin Xu; Roland A Matsouaka; Ying Xian; Lee H Schwamm; Eric E Smith; Deepak L Bhatt; Adrian F Hernandez; Paul A Heidenreich; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2018-07-01       Impact factor: 29.983

Review 3.  Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes.

Authors:  Rong Chen; Bruce Ovbiagele; Wuwei Feng
Journal:  Am J Med Sci       Date:  2016-04       Impact factor: 2.378

4.  Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany.

Authors:  Andrea Icks; Heiner Claessen; Stephan Morbach; Gerd Glaeske; Falk Hoffmann
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

5.  Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data.

Authors:  Janet K Sluggett; Gillian E Caughey; Michael B Ward; Elizabeth E Roughead; Andrew L Gilbert
Journal:  BMC Res Notes       Date:  2013-04-02

6.  Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.

Authors:  Seong-Joon Lee; Ji Man Hong; Sung Eun Lee; Dae Ryong Kang; Bruce Ovbiagele; Andrew M Demchuk; Jin Soo Lee
Journal:  BMC Neurol       Date:  2017-05-19       Impact factor: 2.474

7.  Evaluation of IScore validity in a Greek cohort of patients with type 2 diabetes.

Authors:  Vasileios Dragoumanos; Konstantinos N Tzirogiannis; Georgios I Panoutsopoulos; Konstantinos Krikonis; Evangelos Fousteris; Maria Vourvou; Georgios Elesnitsalis; Nikolaos Melas; Kalliopi T Kourentzi; Andreas Melidonis
Journal:  BMC Neurol       Date:  2013-09-16       Impact factor: 2.474

Review 8.  Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus.

Authors:  Onno N Groeneveld; L Jaap Kappelle; Geert Jan Biessels
Journal:  J Diabetes Investig       Date:  2015-10-03       Impact factor: 4.232

9.  Impact of Diabetes on Stroke Risk and Outcomes: Two Nationwide Retrospective Cohort Studies.

Authors:  Chien-Chang Liao; Chun-Chuan Shih; Chun-Chieh Yeh; Yi-Cheng Chang; Chaur-Jong Hu; Jaung-Geng Lin; Ta-Liang Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

10.  Sex differences in outcomes and associated factors among stroke patients with small artery occlusion in China.

Authors:  Qing Qiao; Yan Hong; Wenjuan Zhao; Guanen Zhou; Qian Liu; Xianjia Ning; Jinghua Wang; Zhongping An
Journal:  Biol Sex Differ       Date:  2018-08-02       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.